Caloric restriction and its effect on blood pressure, heart rate variability and arterial stiffness and dilatation: A review of the evidence

International Journal of Molecular Sciences

Volumn 19, Issue 3, 2018, Pages

  Nicoll, Rachel ^a   Henein, Michael Y ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Arterial stiffness; Blood pressure; Caloric restriction fasting; Flow mediated dilatation; Heart rate variability

Indexed keywords

ANTIHYPERTENSIVE AGENT; NITRIC OXIDE; SIRTUIN 1; BIOLOGICAL MARKER;

ARTERIAL STIFFNESS; ARTERY DILATATION; BLOOD FLOW; BLOOD PRESSURE MONITORING; CALORIC RESTRICTION; CLINICAL EFFECTIVENESS; ENDOTHELIAL DYSFUNCTION; ETHNICITY; EVIDENCE BASED PRACTICE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; HYPOTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANIMAL; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; DISEASE PREDISPOSITION; ENDOTHELIUM; HEALTH SURVEY; HEART RATE; HEMODYNAMICS; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BIOMARKERS; BLOOD PRESSURE; CALORIC RESTRICTION; DISEASE SUSCEPTIBILITY; ENDOTHELIUM; HEART RATE; HEMODYNAMICS; HUMANS; HYPERTENSION; METABOLIC SYNDROME; PUBLIC HEALTH SURVEILLANCE; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 85043595673     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19030751     Document Type: Review

References (101)

1. Poulter, N.R.; Prabhakaran, D.; Caulfield, M. Hypertension. Lancet 2015, 386, 801-812.
2. Carretero, O.A.; Oparil, S. Essential hypertension. Part I: Definition and etiology. Circulation 2000, 101, 329-335.
3. Spelta, F.; Bertozzi, B.; Cominacini, L.; Fontana, L. Calorie restriction, endothelial function and blood pressure homeostasis. Vasc. Pharmacol. 2015, 65-66.
4. Blumenthal, J.A.; Babyak, M.A.; Sherwood, A.; Craighead, L.; Lin, P.H.; Johnson, J.; Watkins, L.L.; Wang, J.T.; Kuhn, C.; Feinglos, M. et al. Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids. Hypertension 2010, 55, 1199-1205.
5. Messerli, F.H.; Williams, B.; Ritz, E. Essential hypertension. Lancet 2007, 370, 591-603.
6. Mertens, I.L.; Van Gaal, L.F. Overweight, obesity, and blood pressure: The effects of modest weight reduction. Obes. Res. 2000, 8, 270-278.
7. Caetano, J.; Delgado Alves, J. Heart rate and cardiovascular protection. Eur. J. Intern. Med. 2015, 26, 217-222.
8. Stein, P.K.; Soare, A.; Meyer, T.E.; Cangemi, R.; Holloszy, J.O.; Fontana, L. Caloric restriction may reverse age-related autonomic decline in humans. Aging Cell 2012, 11, 644-650.
9. Hillis, G.S.; Woodward, M.; Rodgers, A.; Chow, C.K.; Li, Q.; Zoungas, S.; Patel, A.; Webster, R.; Batty, G.D.; Ninomiya, T. et al. Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia 2012, 55, 1283-1290.
10. Hillis, G.S.; Hata, J.; Woodward, M.; Perkovic, V.; Arima, H.; Chow, C.K.; Zoungas, S.; Patel, A.; Poulter, N.R.; Mancia, G. Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus. J. Am. Heart Assoc. 2012, 1, e002832.
11. Dekker, J.M.; Girman, C.; Rhodes, T.; Perkovic, V.; Arima, H.; Chow, C.K.; Zoungas, S.; Patel, A.; Poulter, N.R.; Mancia, G. et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005, 112, 666-673.
12. Mitchell, G.F.; Hwang, S.J.; Vasan, R.S.; Larson, M.G.; Pencina, M.J.; Hamburg, N.M.; Vita, J.A.; Levy, D.; Benjamin, E.J. Arterial stiffness and cardiovascular events: The framingham heart study. Circulation 2010, 121, 505-511.
13. Raitakari, O.T.; Celermajer, D.S. Testing for endothelial dysfunction. Ann. Med. 2000, 32, 293-304.
14. Green, D.J.; Jones, H.; Thijssen, D.; Cable, N.T.; Atkinson, G. Flow-Mediated Dilation and Cardiovascular Event Prediction—Does Nitric Oxide Matter? Hypertension 2011, 57, 363-369.
15. Klempel, M.C.; Kroeger, C.M.; Norkeviciute, E.; Goslawski, M.; Phillips, S.A.; Varady, K.A. Benefit of a low-fat over high-fat diet on vascular health during alternate day fasting. Nutr. Diabetes 2013, 3.
16. Neal, B.; MacMahon, S.; Chapman, N. Blood Pressure Lowering Treatment Trialists C. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet 2000, 356, 1955-1964.
17. Joint National Committee on Prevention, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; NIH Publication 04-5230; US Department of Health and Human Services: Bethesda, MD, USA, 2004.
18. Appel, L.J.; Moore, T.J.; Obarzanek, E.; Vollmer, W.M.; Svetkey, L.P.; Sacks, F.M.; Bray, G.A.; Vogt, T.M.; Cutler, J.A.; Windhauser, M.M. et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 1997, 336, 1117-1124.
19. Sacks, F.M.; Svetkey, L.P.; Vollmer, W.M.; Appel, L.J.; Bray, G.A.; Harsha, D.; Obarzanek, E.; Conlin, P.R.; Miller, E.R., 3rd; Simons-Morton, D.G. et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N. Engl. J. Med. 2001, 344, 3-10.
20. Raitakari, M.; Ilvonen, T.; Ahotupa, M.; Lehtimäki, T.; Harmoinen, A.; Suominen, P.; Elo, J.; Hartiala, J.; Raitakari, O.T.Weight reduction with very-low-caloric diet and endothelial function in overweight adults: Role of plasma glucose. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 124-128.
21. Ruggenenti, P.; Abbate, M.; Ruggiero, B.; Rota, S.; Trillini, M.; Aparicio, C.; Parvanova, A.; Iliev, I.P.; Pisanu, G.; Perna, A. et al. Renal and Systemic Effects of Calorie Restriction in Type-2 Diabetes Patients with Abdominal Obesity: A Randomized Controlled Trial. Diabetes 2017, 66, 75-86.
22. Li, C.; Sadraie, B.; Steckhan, N.; Kessler, C.; Stange, R.; Jeitler, M.; Michalsen, A. Effects of A One-week Fasting Therapy in Patients with Type-2 Diabetes Mellitus and Metabolic Syndrome—A Randomized Controlled Explorative Study. Exp. Clin. Endocrinol. Diabetes 2017.
23. Van Schinkel, L.D.; Bakker, L.E.; Jonker, J.T.; De Roos, A.; Pijl, H.; Meinders, A.E.; Jazet, I.M.; Lamb, H.J.; Smit, J.W. Cardiovascular flexibility in middle-aged overweight South Asians vs. white Caucasians: Response to short-term caloric restriction. Nutr. Metab. Cardiovasc. Dis. 2015, 25, 403-410.
24. Hong, K.; Li, Z.; Wang, H.J.; Elashoff, R.; Heber, D. Analysis of weight loss outcomes using VLCD in black and white overweight and obese women with and without metabolic syndrome. Int. J. Obes. 2005, 29, 436-442.
25. Jakobsdottir, S.; van Nieuwpoort, I.C.; van Bunderen, C.C.; de Ruiter, M.B.; Twisk, J.W.; Deijen, J.B.; Veltman, D.J.; Drent, M.L. Acute and short-term effects of caloric restriction on metabolic profile and brain activation in obese, postmenopausal women. Int. J. Obes. 2016, 40, 1671-1678.
26. Most, J.; Gilmore, L.A.; Smith, S.R.; Han, H.; Ravussin, E.; Redman, L.M. Significant Improvement in Cardiometabolic Health in Healthy Non-Obese Individuals during Caloric Restriction-induced Weight Loss and Weight Loss Maintenance. Am. J. Physiol. Endocrinol. Metab. 2017.
27. Li, C.; Ostermann, T.; Hardt, M.; Lüdtke, R.; Broecker-Preuss, M.; Dobos, G.; Michalsen, A. Metabolic and psychological response to 7-day fasting in obese patients with and without metabolic syndrome. Forschende Komplementarmedizin 2013, 20, 413-420.
28. Walford, R.L.; Mock, D.; Verdery, R.; MacCallum, T. Calorie restriction in biosphere 2: Alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. J. Gerontol. A Biol. Sci. Med. Sci. 2002, 57, B211-B224.
29. Erdem, Y.; Özkan, G.; Ulusoy, ¸S.; Arıcı, M.; Derici, Ü.; Şengül, Ş.; Sindel, Ş.; Ertürk, Ş. Turkish Society of Hypertension and Renal Diseases. The effect of intermittent fasting on blood pressure variability in patients with newly diagnosed hypertension or prehypertension. J. Am. Soc. Hypertens. 2018, 12, 42-49.
30. Kawamura, M.; Adachi, T.; Nakajima, J.; Fujiwara, T.; Hiramori, K. Factors that affect calorie-sensitive and calorie-insensitive reduction in blood pressure during short-term calorie restriction in overweight hypertensive women. Hypertension 1996, 27, 408-413.
31. Case, C.C.; Jones, P.H.; Nelson, K.; O’Brian Smith, E.; Ballantyne, C.M. Impact of weight loss on the metabolic syndrome. Diabetes Obes. Metab. 2002, 4, 407-414.
32. Beleslin, B.; Cirić, J.; Zarković, M.; Vujović, S.; Trbojević, B.; Drezgić, M. The effects of three-week fasting diet on blood pressure, lipid profile and glucoregulation in extremely obese patients. Srpski Arhiv Za Celokupno Lekarstvo 2007, 135, 440-446.
33. Sasaki, S.; Higashi, Y.; Nakagawa, K.; Kimura, M.; Noma, K.; Sasaki, S.; Hara, K.; Matsuura, H.; Goto, C.; Oshima, T. et al. A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension. Am. J. Hypertens. 2002, 15, 302-309.
34. Goldhamer, A.C.; Lisle, D.J.; Sultana, P.; Anderson, S.V.; Parpia, B.; Hughes, B.; Campbell, T.C. Medically supervised water-only fasting in the treatment of borderline hypertension. J. Altern. Complement. Med. 2002, 8, 643-650.
35. Goldhamer, A.; Lisle, D.; Parpia, B.; Anderson, S.V.; Campbell, T.C. Medically supervised water-only fasting in the treatment of hypertension. J. Manip. Physiol. Ther. 2001, 24, 335-339.
36. Ghachem, A.; Prudhomme, D.; Rabasa-Lhoret, R.; Brochu, M. Effects of a 6-month caloric restriction induced-weight loss program in obese postmenopausal women with and without the metabolic syndrome: A MONET study. Menopause 2017, 24, 908-915.
37. Volek, J.S.; Feinman, R.D. Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr. Metab. 2005, 2, 31.
38. Nicoll, R. Reversal of obesity: The quest for the optimum dietary regimen. Int. J. Nutr. 2017, 2, 24.
39. Eshghinia, S.; Mohammadzadeh, F. The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women. J. Diabetes Metab. Disord. 2013, 12, 4.
40. Hoddy, K.K.; Bhutani, S.; Phillips, S.A.; Varady, K.A. Effects of different degrees of insulin resistance on endothelial function in obese adults undergoing alternate day fasting. Nutr. Healthy Aging 2016, 4, 63-71.
41. Varady, K.A.; Bhutani, S.; Church, E.C.; Klempel, M.C. Short-term modified alternate-day fasting: A novel dietary strategy for weight loss and cardioprotection in obese adults. Am. J. Clin. Nutr. 2009, 90, 1138-1143.
42. Hoddy, K.K.; Kroeger, C.M.; Trepanowski, J.F.; Barnosky, A.; Bhutani, S.; Varady, K.A. Meal timing during alternate day fasting: Impact on body weight and cardiovascular disease risk in obese adults. Obesity 2014, 22, 2524-2531.
43. Bhutani, S.; Klempel, M.C.; Kroeger, C.M.; Trepanowski, J.F.; Varady, K.A. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity 2013, 21, 1370-1379.
44. Kessler, C.S.; Stange, R.; Schlenkermann, M.; Jeitler, M.; Michalsen, A.; Selle, A.; Raucci, F.; Steckhan, N. A nonrandomized controlled clinical pilot trial on 8 wk of intermittent fasting (24 h/wk). Nutrition 2017.
45. Harvie, M.N.; Pegington, M.; Mattson, M.P.; Frystyk, J.; Dillon, B.; Evans, G.; Cuzick, J.; Jebb, S.A.; Martin, B.; Cutler, R.G. et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: A randomized trial in young overweight women. Int. J. Obes. 2011, 35, 714-727.
46. Meyer, T.E.; Kovács, S.J.; Ehsani, A.A.; Klein, S.; Holloszy, J.O.; Fontana, L. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J. Am. Coll. Cardiol. 2006, 47, 398-402.
47. Fontana, L.; Meyer, T.E.; Klein, S.; Holloszy, J.O. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc. Natl. Acad. Sci. USA 2004, 101, 6659-6663.
48. Williams, C.L.; Hayman, L.L.; Daniels, S.R.; Robinson, T.N.; Steinberger, J.; Paridon, S.; Bazzarre, T.; American Heart Association. Cardiovascular health in childhood: A statement for health professionals on atherosclerosis, hypertension, and obesity in the young (AHOY) of the Council on Cardiovascular Disease in the Young. Circulation 2002, 106, 143-160.
49. Klempel, M.C.; Kroeger, C.M.; Bhutani, S.; Trepanowski, J.F.; Varady, K.A. Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr. J. 2012, 11, 98.
50. Meckling, K.A.; Sherfey, R. A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the Metabolic Syndrome in overweight and obese women. Appl. Physiol. Nutr. Metab. 2007, 32, 743-752.
51. Klempel, M.C.; Kroeger, C.M.; Varady, K.A. Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet. Metabolism 2013, 62, 137-143.
52. Trepanowski, J.F.; Kroeger, C.M.; Barnosky, A.; Klempel, M.C.; Bhutani, S.; Hoddy, K.K.; Gabel, K.; Freels, S.; Rigdon, J.; Rood, J. et al. Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial. JAMA Intern.Med. 2017.
53. De Jonge, L.; Moreira, E.A.; Martin, C.K.; Ravussin, E.; Pennington CALERIE Team. Impact of 6-month caloric restriction on autonomic nervous system activity in healthy, overweight, individuals. Obesity 2010, 18, 414-416.
54. Yassine, H.N.; Marchetti, C.M.; Krishnan, R.K.; Vrobel, T.R.; Gonzalez, F.; Kirwan, J.P. Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults—A randomized clinical trial. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64, 90-95.
55. Wycherley, T.P.; Brinkworth, G.D.; Noakes, M.; Buckley, J.D.; Clifton, P.M. Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes. Diabetes Obes. Metab. 2008, 10, 1062-1073.
56. Thomson, R.L.; Buckley, J.D.; Noakes, M.; Clifton, P.M.; Norman, R.J.; Brinkworth, G.D. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2008, 93, 3373-3380.
57. Lefevre, M.; Redman, L.M.; Heilbronn, L.K.; Smith, J.V.; Martin, C.K.; Rood, J.C.; Greenway, F.L.; Williamson, D.A.; Smith, S.R.; Ravussin, E. et al. Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis 2009, 203, 206-213.
58. Blumenthal, J.A.; Babyak, M.A.; Hinderliter, A.; Watkins, L.L.; Craighead, L.; Lin, P.-H.; Caccia, C.; Johnson, J.; Waugh, R.A.; Sherwood, A. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: The ENCORE Study. Arch. Intern. Med. 2010, 170, 126-135.
59. Law, M.R.; Wald, N.J.; Morris, J.K.; Jordan, R.E. Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials. BMJ 2003, 326, 1427.
60. Nakano, Y.; Oshima, T.; Sasaki, S.; Higashi, Y.; Ozono, R.; Takenaka, S.; Miura, F.; Hirao, H.; Matsuura, H.; Chayama, K. et al. Calorie restriction reduced blood pressure in obesity hypertensives by improvement of autonomic nerve activity and insulin sensitivity. J. Cardiovasc. Pharmacol. 2001, 38 (Suppl. S1), S69-S74.
61. Weiss, E.P.; Albert, S.G.; Reeds, D.N.; Kress, K.S.; McDaniel, J.L.; Klein, S.; Villareal, D.T. Effects of matched weight loss from calorie restriction, exercise, or both on cardiovascular disease risk factors: A randomized intervention trial. Am. J. Clin. Nutr. 2016, 104, 576-586.
62. Facchini, M.; Malfatta, F.; Salba, L.; Fontana, P.; Lafortuna, C.; Sartorio, A. Changes of autonomic cardiac profileafter a 3 week integrated body weight reduction program in severely obese patients. J. Endocrinol. Investig. 2003, 26, 138-142.
63. Herlihy, J.T.; Stacy, C.; Bertrand, H.A. Long-term calorie restriction enhances baroreflex responsiveness in Fischer 344 rats. Am. J. Physiol. 1992, 263, H1021-H1025.
64. Mager, D.E.; Wan, R.; Brown, M.; Cheng, A.; Wareski, P.; Abernethy, D.R.; Mattson, M.P. Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats. FASEB J. 2006, 20, 631-637.
65. Petersen, K.S.; Blanch, N.; Keogh, J.B.; Clifton, P.M. Effect of weight loss on pulse wave velocity: Systematic review and meta-analysis. Arterioscler. Thromb. Vasc. Biol. 2015, 35, 243-252.
66. Donato, A.J.; Walker, A.E.; Magerko, K.A.; Bramwell, R.C.; Black, A.D.; Henson, G.D.; Lawson, B.R.; Lesniewski, L.A.; Seals, D.R. Life-long caloric restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old mice. Aging Cell 2013, 12, 772-783.
67. Khoo, J.; Piantadosi, C.; Duncan, R.; Worthley, S.G.; Jenkins, A.; Noakes, M.; Worthley, M.I.; Lange, K.; Wittert, G.A. Comparing effects of a low-energy diet and a high-protein low-fat diet on sexual and endothelial function, urinary tract symptoms, and inflammation in obese diabetic men. J. Sex. Med. 2011, 8, 2868-2875.
68. Clifton, P.M.; Keogh, J.B.; Foster, P.R.; Noakes, M. Effect of weight loss on inflammatory and endothelial markers and FMD using two low-fat diets. Int. J. Obes. 2005, 29, 1445-1451.
69. Volek, J.S.; Ballard, K.D.; Silvestre, R.; Judelson, D.A.; Quann, E.E.; Forsythe, C.E.; Fernandez, M.L.; Kraemer, W.J. Effects of dietary carbohydrate restriction versus low-fat diet on flow-mediated dilation. Metabolism 2009, 58, 1769-1777.
70. Green, D.J.; Maiorana, A.J.; Tschakovsky, M.E.; Pyke, K.E.; Weisbrod, C.J.; O’Driscoll, G. Relationship between changes in brachial artery flow-mediated dilation and basal release of nitric oxide in subjects with type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H1193-H1199.
71. Sakamoto, S.; Minami, K.; Niwa, Y.; Ohnaka, M.; Nakaya, Y.; Mizuno, A.; Kuwajima, M.; Shima, K. Effect of exercise training and food restriction on endothelium-dependent relaxation in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous NIDDM. Diabetes 1998, 47, 82-86.
72. Galvao, R.; Plavnik, F.L.; Ribeiro, F.F.; Ajzen, S.A.; Christofalo, D.M.; Kohlmann, O., Jr. Effects of different degrees of insulin sensitivity on endothelial function in obese patients. Arquivos Brasileiros Cardiologia 2012, 98, 45-51.
73. Sciacqua, A.; Candigliota, M.; Ceravolo, R.; Scozzafava, A.; Sinopoli, F.; Corsonello, A.; Sesti, G.; Perticone, F. Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care 2003, 26, 1673-1678.
74. Reaven, G.M. Relationships among Insulin Resistance, Type 2 Diabetes, Essential Hypertension, and Cardiovascular Disease: Similarities and Differences. J. Clin. Hypertens. 2011, 13, 238-243.
75. Lima, N.K.; Abbasi, F.; Lamendola, C.; Reaven, G.M. Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am. J. Hypertens. 2009, 22, 106-111.
76. Jung, C.H.; Jung, S.H.; Lee, B.; Rosenberg, M.; Reaven, G.M.; Kim, S.H. Relationship among age, insulin resistance, and blood pressure. J. Am. Soc. Hypertens. 2017, 11, 359-365.
77. Emdin, M.; Gastaldelli, A.; Muscelli, E.; Macerata, A.; Natali, A.; Camastra, S.; Ferrannini, E. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: Effects of weight loss. Circulation 2001, 103, 513-519.
78. Arcaro, G.; Cretti, A.; Balzano, S.; Lechi, A.; Muggeo, M.; Bonora, E.; Bonadonna, R.C. Insulin causes endothelial dysfunction in humans: Sites and mechanisms. Circulation 2002, 105, 576-582.
79. Kim, J.A.; Montagnani, M.; Koh, K.K.; Quon, M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms. Circulation 2006, 113, 1888-1904.
80. Kuboki, K.; Jiang, Z.Y.; Takahara, N.; Ha, S.W.; Igarashi, M.; Yamauchi, T.; Feener, E.P.; Herbert, T.P.; Rhodes, C.J.; King, G.L. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: A specific vascular action of insulin. Circulation 2000, 101, 676-681.
81. Surdackii, A.; Nowicki, M.; Sandmann, J.; Tsikas, D.; Boeger, R.H.; Bode-Boeger, S.M.; Kruszelnicka-Kwiatkowska, O.; Kokot, F.; Dubiel, J.S.; Froelich, J.C. Reduced urinary secretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J. Cardiovasc. Pharmacol. 1999, 33, 652-658.
82. Stuhlinger, M.C.; Abbasi, F.; Chu, J.W.; Chu, J.W. Relationship between insulin resistance and an endogenous nitiric oxide synthase inhibitor. JAMA 2002, 287, 1420-1426.
83. Karaca, U.; Schram, M.T.; Houben, A.J.; Muris, D.M.; Stehouwer, C.D. Microvascular dysfunction as a link between obesity, insulin resistance and hypertension. Diabetes Res. Clin. Pract. 2014, 103, 382-387.
84. McCarty, M.F. A preliminary fast may potentiate response to a subsequent low-salt, low-fat vegan diet in the management of hypertension—Fasting as a strategy for breaking metabolic vicious cycles. Med. Hypotheses 2003, 60, 624-633.
85. Tuck, M.L. Obesity, the sympathetic nervous system and essential hypertension. Hypertension 1992, 19 (Suppl. SI), I-67-I-77.
86. Ikeda, T.; Gomi, T.; Hirawa, N.; Sakurai, J.; Yoshikawa, N. Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. Hypertension 1996, 27, 1180-1186.
87. Chen, H.; Montagnani, M.; Funahashi, T.; Shimomura, I.; Quon, M.J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 2003, 278, 45021-45026.
88. Anderson, E.A.; Mark, A.L. The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension. Hypertension 1993, 21, 136-141.
89. Zavaroni, I.; Ardigo, D.; Rossi, P.C.; Zuccarelli, A.; Pacetti, E.; Monti, L.; Piatti, P.M.; Reaven, G.M. Relationship between plasma nitric oxide concentration and insulin resistance in essential hypertension. Am. J. Hypertens. 2004, 17, 549-552.
90. Dolinsky, V.W.; Dyck, J.R. Calorie restriction and resveratrol in cardiovascular health and disease. Biochim. Biophys. Acta 2011, 1812, 1477-1489.
91. Chou, S.H.; Lee, Y.C.; Huang, C.F.; Wang, Y.R.; Yu, H.P.; Lau, Y.T. Gender-specific effects of caloric restriction on the balance of vascular nitric oxide and superoxide radical. Cardiovasc. Res. 2010, 87, 751-759.
92. Zanetti, M.; Gortan Cappellari, G.; Burekovic, I.; Barazzoni, R.; Stebel, M.; Guarnieri, G. Caloric restriction improves endothelial dysfunction during vascular aging: Effects on nitric oxide synthase isoforms and oxidative stress in rat aorta. Exp. Gerontol. 2010, 45, 848-855.
93. Rippe, C.; Lesniewski, L.; Connell, M.; LaRocca, T.; Donato, A.; Seals, D. Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress. Aging Cell 2010, 9, 304-312.
94. Li, R.; Zhang, H.; Wang, W.; Wang, X.; Huang, Y.; Huang, C.; Gao, F. Vascular insulin resistance in prehypertensive rats: Role of PI3-kinase/Akt/eNOS signaling. Eur. J. Pharmacol. 2010, 628, 140-147.
95. García-Prieto, C.F.; Pulido-Olmo, H.; Ruiz-Hurtado, G.; Gil-Ortega, M.; Aranguez, I.; Rubio, M.A.; Ruiz-Gayo, M.; Somoza, B.; Fernández-Alfonso, M.S. Mild caloric restriction reduces blood pressure and activates endothelial AMPK-PI3K-Akt-eNOS pathway in obese Zucker rats. Vasc. Pharmacol. 2015, 65-66, 3-12.
96. Dolinsky, V.W.; Morton, J.S.; Oka, T.; Robillard-Frayne, I.; Bagdan, M.; Lopaschuk, G.D.; Des Rosiers, C.; Walsh, K.; Davidge, S.T.; Dyck, J.R. Calorie restriction prevents hypertension and cardiac hypertrophy in the spontaneously hypertensive rat. Hypertension 2010, 56, 412-421.
97. Korda, M.; Kubant, R.; Patton, S.; Malinski, T. Leptin induced endothelial dysfunction in obesity. Am. J. Physiol. Heart Circ. Physiol. 2008, 295, H1514-H1521.
98. Mattagajasingh, I.; Kim, C.S.; Naqvi, A.; Yamamori, T.; Hoffman, T.A.; Jung, S.B.; DeRicco, J.; Kasuno, K.; Irani, K. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 2007, 104, 14855-14860.
99. Gano, L.B.; Donato, A.J.; Pasha, H.M.; Hearon, C.M., Jr.; Sindler, A.L.; Seals, D.R. The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice. Am. J. Physiol. Heart Circ. Physiol. 2014, 307, H1754-H1763.
100. Ding, M.; Lei, J.; Qu, Y.; Zhang, H.; Xin, W.; Ma, F.; Liu, S.; Li, Z.; Jin, F.; Fu, E. Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats. J. Cardiovasc. Pharmacol. 2015, 65, 562-570.
101. Shinmura, K.; Tamaki, K.; Ito, K.; Yan, X.; Yamamoto, T.; Katsumata, Y.; Matsuhashi, T.; Sano, M.; Fukuda, K.; Suematsu, M. et al. Indispensable role of endothelial nitric oxide synthase in caloric restriction-induced cardioprotection against ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2015, 308, H894-H903.